Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,315 | -15,666 | -64,831 | -55,576 | -42,498 |
| Depreciation Amortization | 4,758 | 2,400 | 6,978 | 5,360 | 3,581 |
| Accounts receivable | 723 | 2,474 | N/A | -815 | 5,342 |
| Accounts payable and accrued liabilities | 1,473 | 4,882 | N/A | -508 | 7,217 |
| Other Working Capital | -5,003 | 1,241 | -22,401 | -1,081 | 11,769 |
| Other Operating Activity | 1,690 | -4,889 | 19,515 | 9,390 | -5,649 |
| Operating Cash Flow | $-21,674 | $-9,558 | $-60,739 | $-43,230 | $-20,238 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,251 | -317 | -1,856 | -1,494 | -557 |
| Purchase Sale Intangibles | -250 | N/A | N/A | 0 | N/A |
| Other Investing Activity | -250 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,501 | $-317 | $-1,856 | $-1,494 | $-557 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 47,000 | 26,915 | N/A | 68,616 | 19,827 |
| Debt Repayment | -18,142 | -209 | N/A | -27 | -27 |
| Common Stock Issued | 682 | N/A | N/A | 111 | 78 |
| Common Stock Repurchased | -6,762 | -6,762 | N/A | N/A | N/A |
| Other Financing Activity | -849 | -811 | 81,642 | -447 | -131 |
| Financing Cash Flow | $21,929 | $19,133 | $81,642 | $68,253 | $19,747 |
| Beginning Cash Position | 21,405 | 21,405 | 2,358 | 2,358 | 2,358 |
| End Cash Position | 20,159 | 30,663 | 21,405 | 25,887 | 1,310 |
| Net Cash Flow | $-1,246 | $9,258 | $19,047 | $23,529 | $-1,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,674 | -9,558 | -60,739 | -43,230 | -20,238 |
| Capital Expenditure | -1,251 | -317 | N/A | -1,495 | -557 |
| Free Cash Flow | -22,925 | -9,875 | -60,739 | -44,725 | -20,795 |